Amylyx Pharmaceuticals, Inc. (AMLX)
Amylyx Pharmaceuticals, Inc. is a commercial-stage biotechnology company, which engages in the provision of therapies for neurodegenerative diseases and amyotrophic lateral sclerosis (ALS). Its commercial product is Relyvrio, also known as Albrioza in Canada. The company was founded by Joshua Cohen and Justin Klee in 2013 and is headquartered in Cambridge, MA.
Address
43 THORNDIKE STREET
CAMBRIDGE, MA 02141
Founded
2013
Number of Employees
384
Website
http://www.amylyx.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)